BARR GENERIC WARFARIN TO BE LAUNCHED IN SUMMER; DUPONT MERCK CONTINUES EFFORTS TO PASS STATE LAWS REQUIRING PHYSICIAN APPROVAL FOR NTI SUBSTITUTION

Barr intends to launch its generic version of warfarin during the summer, the company said following FDA's March 26 approval of the first generic version of DuPont Merck's anticoagulant Coumadin.